MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

23 Mar 2020 Evaluate

Glenmark Pharmaceuticals has informed that the company has enclosed press release, titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin Tablets, 5 mg and 10 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.30
Dr. Reddys Labs. 1172.60
Cipla 1295.10
Lupin 1951.60
Zydus Lifesciences 1111.65
View more..